Titelaufnahme

Titel
The mitigating role of prescription drug monitoring programs in the abuse of prescription drugs / Erica G. Birk (Analysis Group) Glen R. Waddell (University of Oregon and IZA) ; IZA Institute of Labor Economics
VerfasserBirk, Erica G. In der Gemeinsamen Normdatei der DNB nachschlagen ; Waddell, Glen R. In der Gemeinsamen Normdatei der DNB nachschlagen
KörperschaftForschungsinstitut zur Zukunft der Arbeit In der Gemeinsamen Normdatei der DNB nachschlagen
ErschienenBonn, Germany : IZA Institute of Labor Economics, September 2017
Ausgabe
Elektronische Ressource
Umfang1 Online-Ressource (40 Seiten) : Diagramme
SerieDiscussion paper ; no. 10990
URNurn:nbn:de:hbz:5:2-138427 Persistent Identifier (URN)
Zugriffsbeschränkung
 Das Dokument ist frei verfügbar.
Volltexte
The mitigating role of prescription drug monitoring programs in the abuse of prescription drugs [0.35 mb]
Links
Nachweis
Verfügbarkeit In meiner Bibliothek
Zusammenfassung

In response to the epidemic of prescription-drug abuse, now 49 US states have passed legislation to establish Prescription Drug Monitoring Programs (PDMPs). These programs track controlled-substance prescribing and usage behavior in an effort to improve patient outcomes and identify and preempt access by drug abusers. We exploit variation in the timing of implementation across states to identify the effectiveness of PDMPs on reducing opioid abuse. In particular, by considering the role of specific program attributes we offer the strongest evidence to date of the potential for PDMP-type policy to decrease opioidrelated treatment admissions. We also consider heterogeneity across intensity and tenure of use, which reveals that the largest gains are coming from reductions in the number of less-attached users. Overall, these results have important implications for the effective re-design of PDMP policy.